Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Treasury Shares (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Treasury Shares for 2 consecutive years, with $108500.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Treasury Shares changed N/A year-over-year to $108500.0, compared with a TTM value of $108500.0 through Jun 2025, changed N/A, and an annual FY2024 reading of $278188.0, changed N/A over the prior year.
  • Treasury Shares was $108500.0 for Q2 2025 at Kairos Pharma, roughly flat from $108500.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $278188.0 in Q3 2024 and bottomed at $108500.0 in Q1 2025.